Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,050 | -19,513 | -12,148 | -4,802 | -20,545 |
| Depreciation Amortization | 39 | 30 | 19 | 9 | 83 |
| Accounts receivable | -374 | -19 | -67 | 34 | -135 |
| Accounts payable and accrued liabilities | 777 | -332 | 1,714 | -185 | 66 |
| Other Working Capital | 1,576 | 1,623 | 2,374 | 499 | -568 |
| Other Operating Activity | 939 | 1,320 | -1,049 | 349 | 2,808 |
| Operating Cash Flow | $-23,093 | $-16,891 | $-9,157 | $-4,096 | $-18,291 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -9 | -9 | -9 | -158 |
| Investing Cash Flow | $-9 | $-9 | $-9 | $-9 | $-158 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -4,813 |
| Common Stock Issued | 65,138 | 65,138 | 65,138 | 24 | 13 |
| Other Financing Activity | 8,075 | 8,075 | 8,213 | 9,825 | 8,431 |
| Financing Cash Flow | $73,213 | $73,213 | $73,351 | $9,849 | $3,631 |
| Beginning Cash Position | 7,202 | 7,202 | 7,202 | 7,202 | 22,020 |
| End Cash Position | 57,313 | 63,515 | 71,387 | 12,946 | 7,202 |
| Net Cash Flow | $50,111 | $56,313 | $64,185 | $5,744 | $-14,818 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,093 | -16,891 | -9,157 | -4,096 | -18,291 |
| Capital Expenditure | -9 | -9 | -9 | -9 | -158 |
| Free Cash Flow | -23,102 | -16,900 | -9,166 | -4,105 | -18,449 |